Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Meglumine Antimoniate
2. N Methylglucamine Antimonate
3. N-methylglucamine Antimonate
1. Meglumine Antimonate
2. Meglumine Antimoniate
3. N-methylglucamine Antimonate
4. 133-51-7
5. Methylglucamine Antimonate
6. Protostib
7. 75g4tw236w
8. N-methyl Glucamine Antimoniate
9. 2168-rp
10. Einecs 205-108-3
11. Glucantim
12. Unii-75g4tw236w
13. 1-deoxy-1-(methylamino)glucitol Antimonate(v)
14. 1-deoxy-1-(methylamino)-d-glucitol, Compound With Antimonic Acid (1:1)
15. D-glucitol, 1-deoxy-1-(methylamino)-, Compd. With Antimonic Acid (1:1)
16. Glucitol, 1-deoxy-1-(methylamino)-, Compd. With Antimonic Acid (1:1), D-
17. Schembl146372
18. Dtxsid4043935
19. D-glucitol, 1-deoxy-1-(methylamino)-, Trioxoantimonate(1-)
20. Mfcd01725422
21. Meglumine Antimonate [who-dd]
22. Akos025310684
23. Db13732
24. N-methylglucamine Antimonate [mi]
25. 133m517
26. Q2757969
27. (2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentaol Stibenate
28. D-glucitol, 1-deoxy-1-(methylamino)-, Compd. With Antimonic Acid (hsbo3) (1:1)
| Molecular Weight | 365.98 g/mol |
|---|---|
| Molecular Formula | C7H18NO8Sb |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 6 |
| Exact Mass | 365.00705 g/mol |
| Monoisotopic Mass | 365.00705 g/mol |
| Topological Polar Surface Area | 168 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 180 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antiprotozoal Agents
Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)
P - Antiparasitic products, insecticides and repellents
P01 - Antiprotozoals
P01C - Agents against leishmaniasis and trypanosomiasis
P01CB - Antimony compounds
P01CB01 - Meglumine antimonate
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Meglumine Antimonate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Meglumine Antimonate, including repackagers and relabelers. The FDA regulates Meglumine Antimonate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Meglumine Antimonate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Meglumine Antimonate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Meglumine Antimonate supplier is an individual or a company that provides Meglumine Antimonate active pharmaceutical ingredient (API) or Meglumine Antimonate finished formulations upon request. The Meglumine Antimonate suppliers may include Meglumine Antimonate API manufacturers, exporters, distributors and traders.
click here to find a list of Meglumine Antimonate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Meglumine Antimonate DMF (Drug Master File) is a document detailing the whole manufacturing process of Meglumine Antimonate active pharmaceutical ingredient (API) in detail. Different forms of Meglumine Antimonate DMFs exist exist since differing nations have different regulations, such as Meglumine Antimonate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Meglumine Antimonate DMF submitted to regulatory agencies in the US is known as a USDMF. Meglumine Antimonate USDMF includes data on Meglumine Antimonate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Meglumine Antimonate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Meglumine Antimonate suppliers with USDMF on PharmaCompass.
Meglumine Antimonate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Meglumine Antimonate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Meglumine Antimonate GMP manufacturer or Meglumine Antimonate GMP API supplier for your needs.
A Meglumine Antimonate CoA (Certificate of Analysis) is a formal document that attests to Meglumine Antimonate's compliance with Meglumine Antimonate specifications and serves as a tool for batch-level quality control.
Meglumine Antimonate CoA mostly includes findings from lab analyses of a specific batch. For each Meglumine Antimonate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Meglumine Antimonate may be tested according to a variety of international standards, such as European Pharmacopoeia (Meglumine Antimonate EP), Meglumine Antimonate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Meglumine Antimonate USP).
LOOKING FOR A SUPPLIER?
